ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,884Medicare Part D Prescriptions Filled, Including Refills

Rank: 151 out of 1942

$485K Total Retail Price of All Prescriptions

Rank: 112 out of 1942

406 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 406 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 406 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,674 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 604 414 1 1
LISINOPRIL 397 281 2 2
OMEPRAZOLE 383 265 3 4
METOPROLOL TARTRATE 311 225 4 9
LEVOTHYROXINE SODIUM 281 209 5 3
AMLODIPINE BESYLATE 271 214 6 6
FUROSEMIDE 264 206 7 5
WARFARIN SODIUM 264 249 7 11
TRAMADOL HCL 213 144 9 19
GABAPENTIN 196 132 10 16
METFORMIN HCL 157 109 11 10
POTASSIUM CHLORIDE 130 98 12 17
HYDROCHLOROTHIAZIDE 129 104 13 8
ATENOLOL 128 108 14 7
METOPROLOL SUCCINATE 126 105 15 13
TAMSULOSIN HCL 115 55 16 29
CITALOPRAM HBR 110 73 17 15
LOSARTAN POTASSIUM 104 83 18 18
DIOVAN 90 90 19 44
PANTOPRAZOLE SODIUM 89 73 20 48
ATORVASTATIN CALCIUM 88 82 21 14
POLYETHYLENE GLYCOL 3350 84 40 22 28
ALENDRONATE SODIUM 76 60 23 21
FLUTICASONE PROPIONATE 76 58 23 37
PREDNISONE 72 54 25 27
PRAVASTATIN SODIUM 72 67 25 23
ADVAIR DISKUS 71 50 27 35
ROPINIROLE HCL 66 40 28 96
CRESTOR 63 50 29 34
SPIRIVA 62 38 30 57
DONEPEZIL HCL 61 61 31 30
HYDROCODONE-ACETAMINOPHEN 60 33 S3 32 12
MAPAP 59 59 33 104
ALLOPURINOL 57 54 34 26
KLOR-CON M20 56 50 35 97
ZOLPIDEM TARTRATE 56 39 35 25
FINASTERIDE 55 55 37 86
LANTUS SOLOSTAR 52 46 38 54
NEXIUM 51 0 39 58
TRIAMCINOLONE ACETONIDE 50 15 40 71
TRIAMTERENE-HCTZ 50 49 40 36
PROAIR HFA 50 40 40 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.